|
業務類別
|
-- |
|
業務概覽
|
Kuros Biosciences Ltd is a Swiss-based biotech company, focused on developing and commercializing biologic bone graft technologies for musculoskeletal applications, particularly in spine, trauma, extremities, and oncology. It has two reportable segments: i) Medical Devices: This segment includes products such as MagnetOs and Attrax, which are biphasic calcium phosphate (BCP) bone grafts that mimic the porous, trabecular structure of cancellous bone. ii) Legacy Portfolio: This segment includes all non-core products (including Checkmate licensing) that are outside the Group's primary therapeutic focus. The majority of the company's revenue is derived from the Medical Devices segment. Geographically, it generates the maximum revenue from the United States of America. |
| 公司地址
| Wagistrasse 25, Schlieren, Zurich, CHE, 8952 |
| 電話號碼
| +41 447334747 |
| 傳真號碼
| +41 447334740 |
| 公司網頁
| https://www.kurosbio.com |
| 員工數量
| 178 |
| Dr. Joost de Bruijn |
Independent Director |
13/03/2025 |
| Mr. Oliver Walker |
Independent Director |
13/03/2025 |
| Mr. Albert Arp |
Independent Director |
13/03/2025 |
| Mr. Chris Fair |
Independent Director |
13/03/2025 |
| Professor Clemens van Blitterswijk |
Chairman of the Board |
13/03/2025 |
|
|
|
|
